Overview
The Radiotherapy Physics Group is responsible for providing a specialist clinical scientific service to the Oncology Department of the Oxford University Hospitals NHS Foundation Trust. Functions include:
* Carrying out patient radiotherapy treatment planning and checking
* Advising clinical and radiography staff on the physics of radiotherapy
* Performing pre‑treatment patient‑specific dosimetric QA; measuring patient‑received doses and radiotherapy treatment equipment output, including calibration
* Ensuring the safety of patients and staff in a hazardous environment which includes exposure to very high levels of ionising radiation
* Ensuring equipment is operating safely and effectively and investigating complex faults
* Evaluating, selecting, procuring, installing, accepting testing and calibrating high value equipment
Role
The post holder will be the Lead Technologist, in collaboration with the multidisciplinary team, for the provision of a clinical service in Radiotherapy Physics, primarily in a nominated specialist area such as stereotactic radiotherapy or training & development of treatment planning and associated areas.
The post holder will lead, manage and train other Radiotherapy Physics staff, particularly technologists in treatment planning.
Clinical Centre
The OUH Radiotherapy Centre at the Churchill Hospital is a five‑linac, all‑Varian (including Halcyon, TrueBeam) site with CT‑sim, ARIA, Eclipse and HDR brachytherapy unit. Our existing satellite centre in Swindon operates a further two linacs and a CT‑sim. A second satellite centre in Milton Keynes operating a single linac and CT‑sim opened in 2025. Supporting systems include AI auto‑contouring and RadCalc. We have a modern suite of treatment planning functionality including RapidPlan, MCO, HyperArc and Velocity, and we treat with a wide variety of techniques including SRS, SRT, and SABR. We have a range of development work underway and an active computing team working to develop software and scripts for automation and data analysis. Close links are maintained with the CRUK/MRC Oxford Institute for Radiation Oncology and an expanding portfolio of clinical trials.
This advert closes on Tuesday 19 May 2026.
#J-18808-Ljbffr